The best of the rest: High­lights from the be­low-the-fold pre­sen­ta­tions at #ES­MO21

This year’s ES­MO Con­gress has had a ma­jor fo­cus on Big Phar­ma drugs — most no­tably can­di­dates from Mer­ck and As­traZeneca — but there have al­so been …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.